Repurposing Selective Serotonin Reuptake Inhibitors for COVID-19: Rationale and Concerns.
作者信息
Navin Karthick, Kuppili Pooja Patnaik, Menon Vikas
机构信息
Dept. of Psychiatry, Sri Lakshmi Narayana Institute of Medical Sciences, Puducherry, India.
Consultant Psychiatrist, Puducherry, India.
出版信息
Indian J Psychol Med. 2020 Nov 2;42(6):578-580. doi: 10.1177/0253717620963338. eCollection 2020 Nov.
Abstract
摘要
相似文献
1
Repurposing Selective Serotonin Reuptake Inhibitors for COVID-19: Rationale and Concerns.将选择性5-羟色胺再摄取抑制剂用于治疗新型冠状病毒肺炎：理论依据与担忧
Indian J Psychol Med. 2020 Nov 2;42(6):578-580. doi: 10.1177/0253717620963338. eCollection 2020 Nov.
2
Case-Control Study Examining the Association between Selective Serotonin Reuptake Inhibitors Use and Hepatocellular Carcinoma.病例对照研究：考察选择性5-羟色胺再摄取抑制剂的使用与肝细胞癌之间的关联
Front Pharmacol. 2017 Nov 22;8:861. doi: 10.3389/fphar.2017.00861. eCollection 2017.
3
Using Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in Critical Care: A Systematic Review of the Evidence for Benefit or Harm.在重症监护中使用选择性5-羟色胺再摄取抑制剂和5-羟色胺-去甲肾上腺素再摄取抑制剂：对有益或有害证据的系统评价
Crit Care Med. 2017 Jun;45(6):e607-e616. doi: 10.1097/CCM.0000000000002308.
4
Risk of Hip Fracture in Older People Using Selective Serotonin Reuptake Inhibitors and Other Psychoactive Medicines Concurrently: A Matched Case-Control Study in Australia.老年人同时使用选择性5-羟色胺再摄取抑制剂和其他精神活性药物时髋部骨折的风险：澳大利亚一项匹配病例对照研究
Drugs Real World Outcomes. 2017 Jun;4(2):87-96. doi: 10.1007/s40801-017-0107-8.
5
Relationship between Recurrent Falls and Medication Use during Acute-Care Hospitalization: A Retrospective Descriptive Study.反复跌倒与急性住院期间用药的关系：一项回顾性描述性研究。
Biol Pharm Bull. 2019;42(7):1192-1198. doi: 10.1248/bpb.b19-00116.
6
Clomipramine use in obsessive-compulsive disorder.氯米帕明在强迫症中的应用。
Expert Rev Neurother. 2002 Nov;2(6):783-90. doi: 10.1586/14737175.2.6.783.
7
Effects of serotonin-norepinephrine reuptake inhibitors on locomotion and prefrontal monoamine release in spontaneously hypertensive rats.5-羟色胺-去甲肾上腺素再摄取抑制剂对自发性高血压大鼠运动和前额叶单胺释放的影响。
Eur J Pharmacol. 2013 Feb 28;702(1-3):250-7. doi: 10.1016/j.ejphar.2013.01.033. Epub 2013 Jan 30.
8
Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats.选择性去甲肾上腺素再摄取抑制剂瑞波西汀在大鼠中的辨别性刺激特性。
Psychopharmacology (Berl). 2001 Nov;158(2):213-8. doi: 10.1007/s002130100895.
9
Antinociceptive effects of monoamine reuptake inhibitors administered alone or in combination with mu opioid agonists in rhesus monkeys.单胺再摄取抑制剂单独或与μ阿片受体激动剂联合给药对恒河猴的镇痛作用。
Psychopharmacology (Berl). 1998 Jan;135(1):99-106. doi: 10.1007/s002130050490.
10
Editorial comment: serotonin syndrome after cardiopulmonary bypass: a case demonstrating the interaction between methylene blue and selective serotonin reuptake inhibitors and serotonin syndrome caused by administration of methylene blue to a patient receiving selective serotonin reuptake inhibitors.
A A Case Rep. 2014 May 1;2(9):115. doi: 10.1213/XAA.0000000000000011.
引用本文的文献
1
Selective serotonin reuptake inhibitors: New hope in the fight against COVID-19.选择性5-羟色胺再摄取抑制剂：对抗新冠病毒的新希望。
Front Pharmacol. 2022 Nov 30;13:1036093. doi: 10.3389/fphar.2022.1036093. eCollection 2022.
2
Does serotonin deficiency lead to anosmia, ageusia, dysfunctional chemesthesis and increased severity of illness in COVID-19?5-羟色胺缺乏是否会导致 COVID-19 患者嗅觉丧失、味觉丧失、化学感觉功能障碍和疾病严重程度增加？
Med Hypotheses. 2021 Aug;153:110627. doi: 10.1016/j.mehy.2021.110627. Epub 2021 Jun 6.
本文引用的文献
1
Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine.通过临床许可的酸性鞘磷脂酶（FIASMA）功能抑制剂，包括抗抑郁药氟西汀，靶向内溶酶体宿主-SARS-CoV-2 界面。
Emerg Microbes Infect. 2020 Dec;9(1):2245-2255. doi: 10.1080/22221751.2020.1829082.
2
What about COVID-19 and arachidonic acid pathway?那么 COVID-19 和花生四烯酸途径呢？
Eur J Clin Pharmacol. 2020 Nov;76(11):1501-1504. doi: 10.1007/s00228-020-02941-w. Epub 2020 Jun 25.
3
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.COVID-19 中的免疫反应：通过靶向 SARS-CoV-2 触发的途径来应对药理学挑战。
Signal Transduct Target Ther. 2020 May 29;5(1):84. doi: 10.1038/s41392-020-0191-1.
4
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.一种 SARS-CoV-2 蛋白相互作用图谱揭示了药物再利用的靶标。
Nature. 2020 Jul;583(7816):459-468. doi: 10.1038/s41586-020-2286-9. Epub 2020 Apr 30.
5
COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine.迄今为止，COVID-19 冠状病毒研究的总体方法学质量较低：氯喹/羟氯喹就是一个例子。
J Clin Epidemiol. 2020 Jul;123:120-126. doi: 10.1016/j.jclinepi.2020.04.016. Epub 2020 Apr 21.
6
The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.抗抑郁药治疗对血清炎症细胞因子水平的影响：一项荟萃分析。
Neuropsychopharmacology. 2011 Nov;36(12):2452-9. doi: 10.1038/npp.2011.132. Epub 2011 Jul 27.
7
Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression.选择性5-羟色胺再摄取抑制剂（SSRIs）对人T淋巴细胞功能和基因表达的免疫调节作用。
Eur Neuropsychopharmacol. 2007 Dec;17(12):774-80. doi: 10.1016/j.euroneuro.2007.03.010. Epub 2007 May 14.
8
Effects of fluoxetine on cellular immune response in stressed mice.氟西汀对应激小鼠细胞免疫反应的影响。
Neurosci Lett. 2006 Apr 3;396(3):247-51. doi: 10.1016/j.neulet.2005.11.042. Epub 2005 Dec 20.
9
Antibacterial activities of non-antibiotic drugs.
J Antimicrob Chemother. 1993 Sep;32(3):355-65. doi: 10.1093/jac/32.3.355.
Zotero 插件